Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2017
Networking for ovarian rare tumors: a significant breakthrough improving disease management
N Chiannilkulchai, P Pautier, C Genestie, et al.
British Journal of Cancer
|
January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group
P-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Gynecologic Oncology
|
September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
I Vergote, A du Bois, A Floquet, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study
F Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2017
Networking for ovarian rare tumors: a significant breakthrough improving disease management
N Chiannilkulchai, P Pautier, C Genestie, et al.
British Journal of Cancer
|
January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group
P-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Gynecologic Oncology
|
September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
I Vergote, A du Bois, A Floquet, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study
F Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
Page
of 5